Key Statistics for 4105
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (TWD) (ttm)
|Est. EPS (TWD) (12/2013)
|Est. PEG Ratio
|Market Cap (M TWD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (TWD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4105
- Net Income (M/TWD)
TTY Biopharm Co., Ltd. manufactures and markets various kinds of medicines. The company's products encompass a variety of therapeutic segments, including cardiology, gastroenterology, orthopedics and cancer.
More Company Profile & Key Executives for 4105
|Lin Jung-ChinChairman/President||Chang Wen-HuaVice Chairman|
|Hsiao Ying-ChunExecutive Vice President||Huang Chun-YingExecutive Vice President|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.